← Back to Analyst Consensus 
TMCI Hold
TREACE MEDICAL CONCEPTS, INC.
Current Price —
Implied Upside —
Analysts 10
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 10, 2026 (15 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 10, 2026 | Truist Securities | maintain | Hold → Hold | — | 54% |
| Jul 16, 2026 | Truist Securities | maintain | Hold → Hold | — | 54% |
| Mar 2, 2026 | Lake Street | maintain | Buy → Buy | — | 47% |
| Jan 7, 2026 | Stifel | maintain | Hold → Hold | $3 | 53% |
| Dec 18, 2025 | Truist Securities | maintain | Hold → Hold | $3 | 54% |
| Nov 10, 2025 | Truist Securities | reiterate | Hold → Hold | $4 | 54% |
| Nov 7, 2025 | UBS | maintain | Neutral → Neutral | $5.85 | 54% |
| Nov 7, 2025 | JP Morgan | downgrade | Neutral → Underweight | $5 | 54% |
| Nov 7, 2025 | BTIG | downgrade | Buy → Neutral | $0 | 52% |
| Oct 15, 2025 | Truist Securities | maintain | Hold → Hold | $7 | 54% |
| Sep 4, 2025 | Truist Securities | maintain | Hold → Hold | $8 | 54% |
| Aug 8, 2025 | UBS | maintain | Neutral → Neutral | $6.5 | 54% |
| Aug 8, 2025 | Stifel | maintain | Hold → Hold | $6 | 53% |
| May 9, 2025 | UBS | maintain | Neutral → Neutral | $8.6 | 54% |
| Apr 11, 2025 | Truist Securities | maintain | Hold → Hold | $8 | 54% |
| Mar 13, 2025 | Truist Securities | maintain | Hold → Hold | $9.5 | 54% |
| Mar 3, 2025 | Truist Securities | maintain | Hold → Hold | $10 | 54% |
| Dec 31, 2024 | Lake Street | initiate | — → Buy | $14.5 | 47% |
| Dec 18, 2024 | Truist Securities | maintain | Hold → Hold | $8.4 | 54% |
| Nov 6, 2024 | Stifel | maintain | Hold → Hold | $8 | 53% |
| Oct 14, 2024 | Truist Securities | maintain | Hold → Hold | $6 | 54% |
| Aug 7, 2024 | UBS | maintain | Neutral → Neutral | $7 | 54% |
| Aug 7, 2024 | Truist Securities | maintain | Hold → Hold | $7.5 | 54% |
| Jul 16, 2024 | Truist Securities | maintain | Hold → Hold | $9 | 54% |
| Jul 15, 2024 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $8 | 54% |
| May 16, 2024 | UBS | downgrade | Buy → Neutral | $6.5 | 54% |
| May 8, 2024 | Morgan Stanley | downgrade | Overweight → Equal-Weight | $5.5 | 54% |
| May 8, 2024 | UBS | maintain | Buy → Buy | $16 | 54% |
| May 8, 2024 | Truist Securities | downgrade | Buy → Hold | $7 | 54% |
| May 8, 2024 | JP Morgan | downgrade | Overweight → Neutral | $8 | 54% |
| May 8, 2024 | BTIG | downgrade | Buy → Neutral | $0 | 52% |
| May 8, 2024 | Stifel | downgrade | Buy → Hold | $6 | 53% |
| Dec 22, 2023 | Truist Securities | maintain | Buy → Buy | $16 | 54% |
| Nov 13, 2023 | Morgan Stanley | maintain | Overweight → Overweight | $14 | 54% |
| Nov 10, 2023 | Stifel | maintain | Buy → Buy | $11 | 53% |
| Nov 10, 2023 | Truist Securities | maintain | Buy → Buy | $12 | 54% |
| Oct 2, 2023 | Stifel | reiterate | Buy → Buy | $28 | 53% |
| Sep 29, 2023 | UBS | initiate | — → Buy | $24 | 54% |
| Sep 12, 2023 | Stephens & Co. | reiterate | Equal-Weight → Equal-Weight | $25 | 54% |
| Aug 28, 2023 | BTIG | maintain | Buy → Buy | $27 | 52% |
| Aug 10, 2023 | Stephens & Co. | maintain | Equal-Weight → Equal-Weight | $25 | 54% |
| Aug 9, 2023 | Truist Securities | maintain | Buy → Buy | $30 | 54% |
| Jun 2, 2023 | Stephens & Co. | reiterate | Equal-Weight → Equal-Weight | $27 | 54% |
| May 1, 2023 | Truist Securities | initiate | — → Buy | $33 | 54% |
| Apr 17, 2023 | BTIG | maintain | — → Buy | $32 | 52% |
| Apr 11, 2023 | Stephens & Co. | initiate | — → Equal-Weight | $26 | 54% |
| Mar 8, 2023 | Morgan Stanley | maintain | — → Overweight | $30 | 54% |
| Oct 11, 2022 | Morgan Stanley | maintain | — → Overweight | $28 | 54% |
| Sep 21, 2022 | BTIG | maintain | — → Buy | $28 | 52% |
| Sep 21, 2022 | Stifel | maintain | — → Buy | $27 | 53% |
Price Target Trend
May 28, 2026 Oct 26, 2026
EPS Estimates
0q —
0y —
+1y —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days